Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SHY-ONC6 in Participants With Advanced or Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07705334
Title field or adapter rule
{'original_value': 'A Phase 1 Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SHY-ONC6 in Participants With Advanced or Metastatic Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:22.726264+00:00
Published At
2026-10-22T00:00:00+00:00
Record Updated At
2026-10-22
Source Retrieved At
2026-10-31T22:18:22.973355+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced or Metastatic Solid Tumors", "Triple Negative Breast Cancer (TNBC)", "HR+ Breast Cancer", "Colon Cancer", "Gastric Cancer", "Hepatecellular Carcinoma", "NSCLC (Advanced Non-small Cell Lung Cancer)", "Mesothelioma", "Pancreatic Carcinoma Metastatic", "Hormone Refractory Prostate Cancer", "Soft Tissue Sarcomas"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-22", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07705334"
protocolSection.identificationModule.officialTitle
"A Phase 1 Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SHY-ONC6 in Participants With Advanced or Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Advanced or Metastatic Solid Tumors (protocolSection.conditionsModule.conditions)
  • Triple Negative Breast Cancer (TNBC) (protocolSection.conditionsModule.conditions)
  • HR+ Breast Cancer (protocolSection.conditionsModule.conditions)
  • Colon Cancer (protocolSection.conditionsModule.conditions)
  • Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Hepatecellular Carcinoma (protocolSection.conditionsModule.conditions)
  • NSCLC (Advanced Non-small Cell Lung Cancer) (protocolSection.conditionsModule.conditions)
  • Mesothelioma (protocolSection.conditionsModule.conditions)
  • Pancreatic Carcinoma Metastatic (protocolSection.conditionsModule.conditions)
  • Hormone Refractory Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Soft Tissue Sarcomas (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['SHY-ONC6'], 'description': 'Participants receive SHY-ONC6 administered orally once daily in 21-day cycles. SHY-ONC6 will be administered until the participant withdraws from study, experiences unacceptable toxicity or other safety event, or their disease progresses.', 'name': 'SHY-ONC6', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • SHY-ONC6 (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.